Advances in Cardiovascular Imaging Imaging Phenotype versus Genotype in Hypertrophic Cardiomyopathy State-of-the Art in Genetics of Hcm Sarcomere and Z-disc Protein Gene Mutations State-of-the-art in Imaging in Hcm Assessment of Morphology
暂无分享,去创建一个
Cleveland Clinic Foundation | M. Desai | S. Ommen | H. Lever | William J Mckenna | Perry M. Elliott | Cleveland Clinic
[1] M. Desai,et al. Management of hypertrophic cardiomyopathy. , 1993, Heart disease and stroke : a journal for primary care physicians.
[2] A. Keren,et al. Genetic counselling and testing in cardiomyopathies: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. , 2010, European heart journal.
[3] Deborah H. Kwon,et al. Characteristics and surgical outcomes of symptomatic patients with hypertrophic cardiomyopathy with abnormal papillary muscle morphology undergoing papillary muscle reorientation. , 2010, The Journal of thoracic and cardiovascular surgery.
[4] M. Desai,et al. Aortic stiffness independently predicts exercise capacity in hypertrophic cardiomyopathy: a multimodality imaging study , 2010, Heart.
[5] A. Tajik,et al. Characteristics and Clinical Significance of Late Gadolinium Enhancement by Contrast-Enhanced Magnetic Resonance Imaging in Patients With Hypertrophic Cardiomyopathy , 2010, Circulation. Heart failure.
[6] Raffaele Izzo,et al. Melusin gene (ITGB1BP2) nucleotide variations study in hypertensive and cardiopathic patients , 2009, BMC Medical Genetics.
[7] M. Desai,et al. Delayed hyper-enhancement magnetic resonance imaging provides incremental diagnostic and prognostic utility in suspected cardiac amyloidosis. , 2009, JACC. Cardiovascular imaging.
[8] M. Desai,et al. Aortic stiffness is increased in hypertrophic cardiomyopathy with myocardial fibrosis: novel insights in vascular function from magnetic resonance imaging. , 2009, Journal of the American College of Cardiology.
[9] J. Towbin,et al. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. , 2009, Journal of the American College of Cardiology.
[10] N. Smedira,et al. Cardiac magnetic resonance detection of myocardial scarring in hypertrophic cardiomyopathy: correlation with histopathology and prevalence of ventricular tachycardia. , 2009, Journal of the American College of Cardiology.
[11] N. Smedira,et al. Steep left ventricle to aortic root angle and hypertrophic obstructive cardiomyopathy: study of a novel association using three-dimensional multimodality imaging , 2009, Heart.
[12] W. Manning,et al. Response to Letter Regarding Article, “Prevalence, Clinical Significance, and Natural History of Left Ventricular Apical Aneurysms in Hypertrophic Cardiomyopathy” , 2009 .
[13] K. Rauen,et al. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation. , 2009, Current opinion in genetics & development.
[14] Scott D Flamm,et al. Association between regional ventricular function and myocardial fibrosis in hypertrophic cardiomyopathy assessed by speckle tracking echocardiography and delayed hyperenhancement magnetic resonance imaging. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[15] Luigi Rega,et al. Assessment and significance of left ventricular mass by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, Journal of the American College of Cardiology.
[16] C. Rochitte,et al. Value of Real Time Three‐Dimensional Echocardiography in Patients with Hypertrophic Cardiomyopathy: Comparison with Two‐Dimensional Echocardiography and Magnetic Resonance Imaging , 2008, Echocardiography.
[17] N. Smedira,et al. Diagnostic value of left ventricular outflow area in patients with hypertrophic cardiomyopathy: a real-time three-dimensional echocardiographic study. , 2008, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[18] Rachael,et al. Myofilament protein gene mutation screening and outcome of patients with hypertrophic cardiomyopathy. , 2008, Mayo Clinic proceedings.
[19] W. Manning,et al. Occurrence and frequency of arrhythmias in hypertrophic cardiomyopathy in relation to delayed enhancement on cardiovascular magnetic resonance. , 2008, Journal of the American College of Cardiology.
[20] W. Manning,et al. Significance of papillary muscle abnormalities identified by cardiovascular magnetic resonance in hypertrophic cardiomyopathy. , 2008, The American journal of cardiology.
[21] Mario J. Garcia,et al. Association of myocardial fibrosis, electrocardiography and ventricular tachyarrhythmia in hypertrophic cardiomyopathy: a delayed contrast enhanced MRI study , 2008, The International Journal of Cardiovascular Imaging.
[22] S. Ommen,et al. Evaluation of Left Ventricular Filling Pressures by Doppler Echocardiography in Patients With Hypertrophic Cardiomyopathy: Correlation With Direct Left Atrial Pressure Measurement at Cardiac Catheterization , 2007, Circulation.
[23] S. Ommen,et al. Abstract 539: Molecular and Functional Characterization of Novel Hypertrophic Cardiomyopathy Susceptibility Mutations in TNNC1-Encoded Troponin C , 2007 .
[24] Mario J. Garcia,et al. Abnormal papillary muscle morphology is independently associated with increased left ventricular outflow tract obstruction in hypertrophic cardiomyopathy , 2007, Heart.
[25] M. Robson,et al. Evidence for Microvascular Dysfunction in Hypertrophic Cardiomyopathy: New Insights From Multiparametric Magnetic Resonance Imaging , 2007, Circulation.
[26] J. Zamorano,et al. Cardiac manifestations of Anderson-Fabry disease: results from the international Fabry outcome survey. , 2007, European heart journal.
[27] A. Tajik,et al. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy. , 2007, Journal of the American College of Cardiology.
[28] Michael J Ackerman,et al. Echocardiographic-determined septal morphology in Z-disc hypertrophic cardiomyopathy. , 2006, Biochemical and biophysical research communications.
[29] Michael J Ackerman,et al. Echocardiography-guided genetic testing in hypertrophic cardiomyopathy: septal morphological features predict the presence of myofilament mutations. , 2006, Mayo Clinic proceedings.
[30] Lynn Weinert,et al. Use of real-time 3-dimensional transthoracic echocardiography in the evaluation of mitral valve disease. , 2006, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[31] W. Mckenna,et al. Historical trends in reported survival rates in patients with hypertrophic cardiomyopathy , 2005, Heart.
[32] J. Seidman,et al. Compound and double mutations in patients with hypertrophic cardiomyopathy: implications for genetic testing and counselling , 2005, Journal of Medical Genetics.
[33] Michael Jerosch-Herold,et al. Utility of Cardiac Magnetic Resonance Imaging in the Diagnosis of Hypertrophic Cardiomyopathy , 2005, Circulation.
[34] R. Kim,et al. Delayed enhancement cardiovascular magnetic resonance assessment of non-ischaemic cardiomyopathies. , 2005, European heart journal.
[35] T. Kato,et al. Discrimination of Nonobstructive Hypertrophic Cardiomyopathy From Hypertensive Left Ventricular Hypertrophy on the Basis of Strain Rate Imaging by Tissue Doppler Ultrasonography , 2004, Circulation.
[36] A. Tajik,et al. Myosin binding protein C mutations and compound heterozygosity in hypertrophic cardiomyopathy. , 2004, Journal of the American College of Cardiology.
[37] P. Dimitrow,et al. Delayed contrast enhancement of MRI in hypertrophic cardiomyopathy. , 2004, Magnetic Resonance Imaging.
[38] C. Asher,et al. Safety of stress testing in patients with hypertrophic cardiomyopathy. , 2004, The American journal of cardiology.
[39] D. Pennell,et al. Detection of apical hypertrophic cardiomyopathy by cardiovascular magnetic resonance in patients with non-diagnostic echocardiography , 2004, Heart.
[40] J. Towbin,et al. Characterization of Left Ventricular Diastolic Function by Tissue Doppler Imaging and Clinical Status in Children With Hypertrophic Cardiomyopathy , 2004, Circulation.
[41] Barry J Maron,et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice G , 2003, Journal of the American College of Cardiology.
[42] I. Olivotto,et al. Coronary microvascular dysfunction and prognosis in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.
[43] Daniel B Ennis,et al. Assessment of regional systolic and diastolic dysfunction in familial hypertrophic cardiomyopathy using MR tagging , 2003, Magnetic resonance in medicine.
[44] M. Quiñones,et al. Tissue Doppler Imaging Predicts the Development of Hypertrophic Cardiomyopathy in Subjects With Subclinical Disease , 2003, Circulation.
[45] S. Dimauro,et al. Mitochondrial respiratory-chain diseases. , 2003, The New England journal of medicine.
[46] D. Pennell,et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. , 2003, Journal of the American College of Cardiology.
[47] Mario J. Garcia,et al. Comparison of left ventricular diastolic function in obstructive hypertrophic cardiomyopathy in patients undergoing percutaneous septal alcohol ablation versus surgical myotomy/myectomy. , 2003, The American journal of cardiology.
[48] F. T. ten Cate,et al. Hypertrophic cardiomyopathy in a large community-based population: clinical outcome and identification of risk factors for sudden cardiac death and clinical deterioration. , 2003, Journal of the American College of Cardiology.
[49] B. Maron,et al. Effect of left ventricular outflow tract obstruction on clinical outcome in hypertrophic cardiomyopathy. , 2003, The New England journal of medicine.
[50] Heiko Mahrholdt,et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. , 2002, Journal of the American College of Cardiology.
[51] A. Tajik,et al. Impact of intraoperative transesophageal echocardiography in the surgical management of hypertrophic cardiomyopathy. , 2002, The American journal of cardiology.
[52] S. Solomon,et al. Assessment of Diastolic Function With Doppler Tissue Imaging to Predict Genotype in Preclinical Hypertrophic Cardiomyopathy , 2002, Circulation.
[53] B. Maron. Hypertrophic cardiomyopathy: a systematic review. , 2002, JAMA.
[54] J. Seidman,et al. Constitutively active AMP kinase mutations cause glycogen storage disease mimicking hypertrophic cardiomyopathy. , 2002, The Journal of clinical investigation.
[55] J. Plana,et al. Efficacy of nonsurgical septal reduction therapy in symptomatic patients with obstructive hypertrophic cardiomyopathy and provocable gradients. , 2001, The American journal of cardiology.
[56] M. Quiñones,et al. Tissue Doppler Imaging Consistently Detects Myocardial Abnormalities in Patients With Hypertrophic Cardiomyopathy and Provides a Novel Means for an Early Diagnosis Before and Independently of Hypertrophy , 2001, Circulation.
[57] H. Watkins,et al. Mutations in the gamma(2) subunit of AMP-activated protein kinase cause familial hypertrophic cardiomyopathy: evidence for the central role of energy compromise in disease pathogenesis. , 2001, Human molecular genetics.
[58] J. Seidman,et al. The Genetic Basis for Cardiomyopathy from Mutation Identification to Mechanistic Paradigms , 2001, Cell.
[59] P. Elliott,et al. Relation between severity of left-ventricular hypertrophy and prognosis in patients with hypertrophic cardiomyopathy , 2001, The Lancet.
[60] D. Szczesna,et al. Abnormal Contractile Function in Transgenic Mice Expressing a Familial Hypertrophic Cardiomyopathy-linked Troponin T (I79N) Mutation* , 2001, The Journal of Biological Chemistry.
[61] P. Elliott,et al. Sudden death in hypertrophic cardiomyopathy: identification of high risk patients. , 2000, Journal of the American College of Cardiology.
[62] J. Seidman,et al. Homozygous Mutation in Cardiac Troponin T: Implications for Hypertrophic Cardiomyopathy , 2000, Circulation.
[63] B. Maron,et al. Magnitude of left ventricular hypertrophy and risk of sudden death in hypertrophic cardiomyopathy. , 2000, The New England journal of medicine.
[64] T. Magnuson,et al. Mice mutant for Egfr and Shp2 have defective cardiac semilunar valvulogenesis , 2000, Nature Genetics.
[65] M. Quiñones,et al. Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. , 1999, Journal of the American College of Cardiology.
[66] J. Seidman,et al. Altered crossbridge kinetics in the alphaMHC403/+ mouse model of familial hypertrophic cardiomyopathy. , 1999, Circulation research.
[67] M. Quiñones,et al. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. , 1999, Circulation.
[68] E. Schwammenthal,et al. Mechanism of mitral regurgitation in hypertrophic cardiomyopathy: mismatch of posterior to anterior leaflet length and mobility. , 1998, Circulation.
[69] M. Verani,et al. Role of myocardial contrast echocardiography during nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. , 1998, Journal of the American College of Cardiology.
[70] H Niimura,et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. , 1998, The New England journal of medicine.
[71] A. Marian,et al. Molecular Genetic Basis of Hypertrophic Cardiomyopathy: , 1998, Journal of cardiovascular electrophysiology.
[72] M. Matsuzaki,et al. Mutations in the cardiac troponin I gene associated with hypertrophic cardiomyopathy , 1997, Nature Genetics.
[73] H. Watkins,et al. Sudden death due to troponin T mutations. , 1997, Journal of the American College of Cardiology.
[74] A J Tajik,et al. Noninvasive doppler echocardiographic evaluation of left ventricular filling pressures in patients with cardiomyopathies: a simultaneous Doppler echocardiographic and cardiac catheterization study. , 1996, Journal of the American College of Cardiology.
[75] I. Rayment,et al. Mutations in either the essential or regulatory light chains of myosin are associated with a rare myopathy in human heart and skeletal muscle , 1996, Nature Genetics.
[76] J. Seidman,et al. Mutations in the cardiac myosin binding protein–C gene on chromosome 11 cause familial hypertrophic cardiomyopathy , 1995, Nature Genetics.
[77] J. Seidman,et al. Mutations in the genes for cardiac troponin T and alpha-tropomyosin in hypertrophic cardiomyopathy. , 1995, The New England journal of medicine.
[78] M. Burch,et al. Hypertrophic cardiomyopathy. , 1994, Archives of disease in childhood.
[79] M. Proschan,et al. Morphology of the "athlete's heart" assessed by echocardiography in 947 elite athletes representing 27 sports. , 1994, The American journal of cardiology.
[80] L. Axel,et al. Regional Heterogeneity of Function in Hypertrophic Cardiomyopathy , 1994, Circulation.
[81] Christine E. Seidman,et al. α-tropomyosin and cardiac troponin T mutations cause familial hypertrophic cardiomyopathy: A disease of the sarcomere , 1994, Cell.
[82] J. Seidman,et al. Characteristics and prognostic implications of myosin missense mutations in familial hypertrophic cardiomyopathy. , 1992, The New England journal of medicine.
[83] J. Seidman,et al. A molecular basis for familial hypertrophic cardiomyopathy: A β cardiac myosin heavy chain gene missense mutation , 1990, Cell.
[84] S. Solomon,et al. Mapping a gene for familial hypertrophic cardiomyopathy to chromosome 14q1. , 1989, The New England journal of medicine.
[85] B. Healy,et al. Hypertrophic cardiomyopathy in the elderly. Distinctions from the young based on cardiac shape. , 1989, Circulation.
[86] W. Williams,et al. Hypertrophic cardiomyopathy. The importance of the site and the extent of hypertrophy. A review. , 1985, Progress in cardiovascular diseases.
[87] D. Judge,et al. Genetic Evaluation of Cardiomyopathy-A Heart Failure Society of America Practice Guideline. , 2018, Journal of cardiac failure.
[88] B. Maron,et al. Hypertrophic Cardiomyopathy Prognostic Value of Systemic Blood Pressure Response During Exercise in a Community-Based Patient Population With Hypertrophic Cardiomyopathy , 2016 .
[89] M. Cheitlin,et al. Myocardial Scar Visualized by Cardiovascular Magnetic Resonance Imaging Predicts Major Adverse Events in Patients With Hypertrophic Cardiomyopathy , 2011 .
[90] N. Smedira,et al. Abnormally thickened papillary muscle resulting in dynamic left ventricular outflow tract obstruction: an unusual presentation of hypertrophic cardiomyopathy. , 2009, Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography.
[91] O. Kamp,et al. Structural abnormalities of the left ventricle in hypertrophic cardiomyopathy mutation carriers detectable before the development of hypertrophy , 2007, Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation.
[92] M. Sheppard,et al. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. , 2006, Journal of cardiovascular magnetic resonance : official journal of the Society for Cardiovascular Magnetic Resonance.
[93] W. Kindermann,et al. [Left ventricular mass in endurance-athletes with athlete's heart and untrained subjects--comparison between different echocardiographic methods and MRI]. , 2003, Zeitschrift fur Kardiologie.
[94] O. Simonetti,et al. An improved MR imaging technique for the visualization of myocardial infarction. , 2001, Radiology.
[95] S. Nagueh,et al. Echocardiographic insights into the mechanisms of relief of left ventricular outflow tract obstruction after nonsurgical septal reduction therapy in patients with hypertrophic obstructive cardiomyopathy. , 2001, Journal of the American College of Cardiology.
[96] A. Børglum,et al. Alpha-cardiac actin is a novel disease gene in familial hypertrophic cardiomyopathy. , 1999, The Journal of clinical investigation.